Targeting of antiviral drugs by coupling with protein carriers
- 7 March 1983
- journal article
- review article
- Published by Wiley in FEBS Letters
- Vol. 153 (1), 6-10
- https://doi.org/10.1016/0014-5793(83)80108-2
Abstract
Side effects of antiviral drugs might be circumvented by their selective delivery into infected cells. This targeting can be obtained by conjugation of the drugs to macromolecules which are taken up specifically by the infected cells. The experiments reviewed, on this approach to antiviral chemotherapy, are mainly directed at improving the chemotherapeutic index of adenine arabinoside (ara-A) in the treatment of chronic hepatitis B by its coupling to galactosyl terminating glycoproteins.Keywords
This publication has 39 references indexed in Scilit:
- Conjugates of adenine 9-α-D-arabinofuranoside monophosphate (ara-AMP) with lactosaminated homologous albumin are not immunogenic in the mouseCellular and Molecular Life Sciences, 1982
- Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine ArabinosideThe Journal of Infectious Diseases, 1981
- VidarabineDrugs, 1980
- An electron microscope autoradiographic study of the carbohydrate recognition systems in rat liver. II. Intracellular fates of the 125I-ligands.The Journal of cell biology, 1979
- HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.BMJ, 1978
- Homing of liposomes to target cellsBiochemical and Biophysical Research Communications, 1975
- In vitro effect of a 5-fluorodeoxyuridine albumin conjugate on tumour cells and on peritoneal macrophagesCellular and Molecular Life Sciences, 1974
- Selective toxicity of amanitin-albumin conjugates for macrophagesCellular and Molecular Life Sciences, 1974
- Hepatic uptake of proteins coupled to fetuin glycopeptideBiochemical and Biophysical Research Communications, 1971
- Effects of α-amanitin on mouse and rat liver cell nuclei1Experimental Cell Research, 1971